CA1058522A - Method of and apparatus for the deep freezing of biological substances - Google Patents
Method of and apparatus for the deep freezing of biological substancesInfo
- Publication number
- CA1058522A CA1058522A CA268,399A CA268399A CA1058522A CA 1058522 A CA1058522 A CA 1058522A CA 268399 A CA268399 A CA 268399A CA 1058522 A CA1058522 A CA 1058522A
- Authority
- CA
- Canada
- Prior art keywords
- temperature
- bioreceptacle
- coolant
- liquid coolant
- deep
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000126 substance Substances 0.000 title claims abstract description 35
- 238000007710 freezing Methods 0.000 title claims abstract description 22
- 230000008014 freezing Effects 0.000 title claims abstract description 14
- 238000000034 method Methods 0.000 title claims description 37
- 238000001816 cooling Methods 0.000 claims abstract description 18
- 230000004083 survival effect Effects 0.000 claims abstract description 8
- 239000002826 coolant Substances 0.000 claims description 39
- 230000008569 process Effects 0.000 claims description 29
- 239000007788 liquid Substances 0.000 claims description 22
- 238000010438 heat treatment Methods 0.000 claims description 17
- 239000007921 spray Substances 0.000 claims description 11
- 239000002184 metal Substances 0.000 claims description 7
- 229910052751 metal Inorganic materials 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 5
- 230000001105 regulatory effect Effects 0.000 claims description 4
- 230000001276 controlling effect Effects 0.000 claims 3
- 239000012530 fluid Substances 0.000 claims 1
- 238000005507 spraying Methods 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 19
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 14
- 238000007654 immersion Methods 0.000 description 8
- 150000002500 ions Chemical class 0.000 description 7
- 229910052757 nitrogen Inorganic materials 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 239000003223 protective agent Substances 0.000 description 5
- 241001593730 Acacia salicina Species 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- KUAZQDVKQLNFPE-UHFFFAOYSA-N thiram Chemical compound CN(C)C(=S)SSC(=S)N(C)C KUAZQDVKQLNFPE-UHFFFAOYSA-N 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- BALXUFOVQVENIU-KXNXZCPBSA-N pseudoephedrine hydrochloride Chemical compound [H+].[Cl-].CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 BALXUFOVQVENIU-KXNXZCPBSA-N 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 238000010257 thawing Methods 0.000 description 3
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
- 239000012503 blood component Substances 0.000 description 2
- 230000005779 cell damage Effects 0.000 description 2
- 208000037887 cell injury Diseases 0.000 description 2
- 210000003850 cellular structure Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 229960005150 glycerol Drugs 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 239000004945 silicone rubber Substances 0.000 description 2
- 229920003002 synthetic resin Polymers 0.000 description 2
- 239000000057 synthetic resin Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- BHMLFPOTZYRDKA-IRXDYDNUSA-N (2s)-2-[(s)-(2-iodophenoxy)-phenylmethyl]morpholine Chemical compound IC1=CC=CC=C1O[C@@H](C=1C=CC=CC=1)[C@H]1OCCNC1 BHMLFPOTZYRDKA-IRXDYDNUSA-N 0.000 description 1
- NSMXQKNUPPXBRG-SECBINFHSA-N (R)-lisofylline Chemical compound O=C1N(CCCC[C@H](O)C)C(=O)N(C)C2=C1N(C)C=N2 NSMXQKNUPPXBRG-SECBINFHSA-N 0.000 description 1
- 235000006696 Catha edulis Nutrition 0.000 description 1
- 240000007681 Catha edulis Species 0.000 description 1
- 241000518994 Conta Species 0.000 description 1
- 241001387976 Pera Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000012809 cooling fluid Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- JCYWCSGERIELPG-UHFFFAOYSA-N imes Chemical class CC1=CC(C)=CC(C)=C1N1C=CN(C=2C(=CC(C)=CC=2C)C)[C]1 JCYWCSGERIELPG-UHFFFAOYSA-N 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F25—REFRIGERATION OR COOLING; COMBINED HEATING AND REFRIGERATION SYSTEMS; HEAT PUMP SYSTEMS; MANUFACTURE OR STORAGE OF ICE; LIQUEFACTION SOLIDIFICATION OF GASES
- F25D—REFRIGERATORS; COLD ROOMS; ICE-BOXES; COOLING OR FREEZING APPARATUS NOT OTHERWISE PROVIDED FOR
- F25D29/00—Arrangement or mounting of control or safety devices
- F25D29/001—Arrangement or mounting of control or safety devices for cryogenic fluid systems
Abstract
ABSTRACT OF THE DISCLOSURE
A system for the deep freezing of biological sub-stances provides an input representing the temperature-time curve required at the outer wall of a receptacle containing biological substances to be deep-frozen while a sensor measures the actual temperature at this wall and controls the cooling applied to the receptacle to conform the cooling at the receptacle wall to the precalculated temperature-time curve. This permits the necessary temperature gradient to be applied to the biological substance for maximum cell survival without any dead time necessitated by the use of sensors within the biological substance itself.
A system for the deep freezing of biological sub-stances provides an input representing the temperature-time curve required at the outer wall of a receptacle containing biological substances to be deep-frozen while a sensor measures the actual temperature at this wall and controls the cooling applied to the receptacle to conform the cooling at the receptacle wall to the precalculated temperature-time curve. This permits the necessary temperature gradient to be applied to the biological substance for maximum cell survival without any dead time necessitated by the use of sensors within the biological substance itself.
Description
~s~s~z Field of the Invention The presen~ invention relates ~o a method o and to an appara~us ~or ~he deep-~reezing of biological substances ln re-specti~re receptacl~s and, more particularly, to the de~p-reez-ing of biological substanees which have b~en introduc2d into s~-c~lled biorecep~acles and are sealed ~herein pr~or ~o being deep-frozen by means o~ a ooolant or refrigerant such as liq~efied nitrogen.
In cryogeni-~ processes for ~he pre~ervation of b~ologi-cal substances such as blood, blood components, cell ~usp~n-sions and cell tissue~, the majnr problem resides in ~voiding irreversible cell d~mage which can ~esult during the ~reezing process and the subsequent th~wing process, or the minimizir~g of such damage .
It has been proposed heretofore to limit th~ cell damage of biological substances o~ ~he ch~racter described by ~he addition of a cryophylactic protective additive or agent which serves to protect the cells against the effec~s of :Ereezi~g 20 and thawing and which is mixed with the cell su~pension or other biological substance. Such protect~ve agents increase ~he sur~ival rate of ~he frozen cell materials.
Pro~ec~ive add~ res such as glycerin have been used here~ofore, especially ~or the protection o blo~d against t~
effects of the deep-freezing process, and must be washed from the preservPd biological substances after thawing because ~hey can adversely afect the human organismO ~C:onsiderable research ~s~szz has gone in~o ~he developmen'c of biologically innocuous pro-tecti~7e addi~ives and, when such are employed, the survival rate can be :incre~sed.
Investigations have shown tha~ an lmportant factor in avoiding the decompositioa or destruction o:E ~e cells is the tempera~ure gradient with which the cells are ro2en. In other words, there are prede~e~minable cell-speciic ~ime-dependen~ temperature gradients ~t which cellular m~-terial, i~,eO the biolo~ical substances described above, ~an be 10 frozen to ob~ain a survi~al ra~e o about 98%. This latter percentage has been found ~o be a reasonable level for mos~
cryogen~c deep-freezing processes and, when reference i5 made herein ~o ~ime-dependent cell-specific temperatur~ gradients, i~ will be unders~ood that such gradients are intended as will ensure a cell survival rate of about 98% following deep ~reez-ing and thawing.
When ~he speed of the freez~ng process lies ben~ath this ~er~pera~ure gradient, the concen~ra~ion of the extra-cellular liquid is increased during the reezing process by 20 the ~reezing out of water therefrom. This results ln an in-crease in the osmotic pressur~ be~ween the inner-cell and outer-cell media. Furthermore, dur-lng the fre~zing process water is wi~hdrawn from the cells themselves and this results in a concen~ration increase in the intracellular solution as well. miS can gi~e rise to den~turation of ~he proteins in the cell interiorsO While the ef~ects of such processes can be minim~ed by an increase in the sp~ed o~ ~he freezing pro~
cessS t~ere ~e~ertheless is a tendency at both excessively high speeds and low speeds ~o produce intercellular ice which, in any case~ breaks down the cell walls and membranes.
~S~5zz Qf course, the amount and type of protective agent will also influence the desired temperature gradien~ o~ the freezing process. For example, when mix~ures of erythrocytes with glyc erin in high concentrations o about 50% are subjec~ed to deep-~reezing at a temperature gradîent of about ~ K/min (8 de-grees Kel~rin or Cen~igrade per minu~e~, high survival rates of the blsod cells are noted. For unprotected erythrocytes, the optimum temperature gradient is about 50~0 E~/min and even a~
this op~lmum, the maximum survival rate o~ the c211s iS found 10 to be only about ~0~0.
Known processes for the deep-cooliIlg preservation o~
biological substances, which can be contained in so-called b~orecep~acles, eithe~ maintain the biological recep~acle in a liquid nitrogen bath for a predetermined time period, some~imes wi~h shaking in order to ensur~ effective mixture o the bio-logical substance wi~h ~he protective agent, or spray ~he bioreceptacle with liquid nitrogen while monitoring the tem-pera~ure within the interior of the recep~acle.
The recept~cle which can be used in the prior~art ~0 systems and in the invention described ~elow can be any syn-the~ic resin sack or other conta~ner con~entionally used to receive mixtures of blood and protective agents or other bio-logical substances admixed with protec~i~e agentsO
By the technique descr~bed above, the freeging process canno~ be accur~tely maintained at a predetermined cell~spe-cific ~empera ture gradientO
The immersion process, which can be limited only as to t~me, does not permit Yariation in the temperature gradien~
under such controls as ~o main~ain a predetermined cell-specific 30 ~emperature gradient and the optimum temperature gradient ~or any specif cell can, at best, only be approach~d.
~s~
me~sp~ay process permits a monitoring o the change of temperature with time by means of a thermoelemen~ in the interior of ~he bioreceptacle~ but has the diæadvantage khat there ls a large ime lag in the con~rol process, i.e. the reaction time between a change in the supply o the coolant and the re~ulting change in the ~empera~re in ~he ~n~erior of ~he bioreceptacle is considerable. This, ~oo, pre~en~s an accurate control of the ~emperature gradien~O
Qb'ects o~ the Invention Xt is the principal ob~ect o the presen~ invention to provide a process and an apparatus for ~he deep~freezing of biological ~ubs~ances contained in b~oreceptacles, in which during the freezing process a cell-specific temperature gradi-ent op~imum for the specific biological substance can be maintained with high precision and high reproducibili~y.
It is another object of ~he ~nventlon ~o provide a sys~em for the deep-~reezing o biological substances, such as those mentioned abo~e, with or without protect~ve agents, whereby the aforementioned disad~antages are avoided.
Summary o~ ~he Invention These ob~ects are attained, in accordance with the present invention, in a system (proces~ and/or appara~us) whereby the temperature of the outer wall of ~he bioreceptacle ~s controlled as a f~n~tion of time to conform ~o the tempera-ture-t~me curve which ~s calculated to respond to the optiswm ~.emperature gradient for any speclfic biological s~bstance at the outer wall of the bioxeceptacleO
In o~her words, according to the in~ention~ when a predete~mined temperature gradient is to be maintained during the freezing process ~o ensure approximately 98% survival ~s~
rate of ~he cells of this biological substance upon deep~
-freezing, the temperature-time curve a~ the outer wall o ~he biorecep~acle necessary to maintain ~his predetermined temper-a~ure gradient is firs~ calcula~ed and ~he deep-freezing process is con~rolled so that the tempe~ature at the outer wall of the bioreceptacle varias as a 1mction o~ time ~o correspond ~o ~his calcula~ed tempera~ure- ~ime curve .
~ y precalcula~ing the temperature- time cun7e or the ou~cer wall of ~he biorecep~acle, which yields the des~red tem-10 perature gradien~ for ~he biological su~s~ance in the interis:rof the bioreceptacle, and by conforming the change in tempera-ture at ~he outer wall of the bioreceptacle wlth time to correspond to this calculated temperature-time curve, it is possible in accor~nce with the in~ention to carry out the freezing process of any given biological substance with the desired temperature gradien~ without concern or dead ~ime, ~hermal inertia or lag time in a control processO
An important charac~eristic of the inven~ion is tha~
it permits a thermoelement in the interior of the biorecep-2û tacle to be completely dispensed wi~h and i~ alæo eliminatesthe effects of long reaction times resul~ing in dela~s in the change in ~h~ temperature within the bioreceptacle.
Becallse of the mathematical solution which is used ~o calculate the ~emperature within ~he biorec~ptacle, all meas-urements of the temperature wi~hin the interior of ~he bio-logical substance in ~he bioreceptacle can be eliminated~. ~he calculation, of course, takes into consideration the thick-ness of ~he wall of the bioreceptacle, the coefficient of thermal conduction thereo, its heat capacity and the heat-30 -transer coefficien~ between the cooling fluid and the receptacle w~ll and between the receptacle wall and the ~OSB5ZZ
biological substances as well as ~he thermal characteris~ics of ~he liquid layers and the interfacial ~hermal characteristics between the receptacle and the fluidso According to one aspec~ of the inven~ion7 the reeæing procQss is controlled ~o correspond ~o th~ c~lculated ~emp~ra-ture-time curve when the bioreceptacle is sprayed with a lique-fied coolan~ especially ni~rogen, and ~he supply o~ ~he cooling medium per unlt ~ime is regulated in dependence ~pon the ~empe~
ature measured at the out~r ~all of the bioreceptacle. A lag in con~rol~ o~ ~he type which occurs when the measurement Qf ~he temperature takes place in the inter~or of the receptacle, is excluded. The desired ~empera~ure gradien~ can be accurat~ly maintailledn According to ano~her aspec~ or ~eature of the invention, the bioreceptacle can be electrically heated externally during the ~reezing process so that the deslred change in temperature with time is maintained at the ou~ex wall of the bioreceptacle which is sub~ec~ed to deep-freeze cooling by~ for e~ample, the spray-cooling t~chni~ue mentioned above or by immersion cooling, 0~ course, in this case~ ~he heat abstracted by the coolant must exceed the heat del~vered by the electrical heating meansO
I~ h~s been found that the electrical hea~ing technique permits a hlghly exact contro~ of the temperature on the external sur-face of the recep~acle and hence main~aines a predetermined temperature gradient.
It has been ~ound to be highly advan~ageous, in the dee~
freeæing of cells and biological substances which require rela-~ively low temperature gradients of ~ew K/min, ~o avoid cell damage, for e~ample for the ~reezing of corpuscular blood com~
ponents such as thrombocy~es or lymphocytes, to provide ~h~
~195~52;2 freezing apparatus with a pair of pla~ces of low ~hermal conduc-tivity and to dispose the bioreceptacle between these plates.
These plates can be composed of synthe~ic resin and have wall thicknesses which are ~alcula~ed, iLn dependence upon the tem-perature-time curve for the outer wall of t:he recep~acle, to provide the desired temperature as a function of ~cime a~ this outer wall. The assembly of the low-~hermal-conduc~iYity plates and the bioreceptacle can ~hen be immersed in a lique-~ied gas~ e.g. liqu~fied nitrogen~ forming the coolant bathO
The bior~ceptacle can also be hea~ed, preferably elec-trically, along its external sur~ace even in ~he immersion, to maintain the temperature function of ~ime at the ex~rnal sur-face of the receptacle in conformity with ~he calculated tem-perature- time curve .
In this case, the desired temperature grad~ent can be provided as a first appro~ ion by the controll of the wall ~hickness of the plates o low-thermal-conductivity material and can be corr~cted by heating the outer wall of ~he biore-ceptacle in response to an actual measurement of the tempera~
ture a~ this wall, the measured temper~ture being compared with ~he calculated tempera~ure at any ins~ant ln time of the temper-ature-time curve to produce an error signal which controls the heating.
The low-heat-conductivity pla~es ~hus provide a ooa~se control o the freezing speed while the heating operation main-tains the fine control thereof.
An ~pparatus for carrying ou~ the process o~ the pr~sent invention, using the spray-cooling technique, advantageously comprises a cooling channel disposed in a sterile chamber and 30 pxovided wi~h feed means for supplying the liquefi~d coolan~
~ ~ ~ 8 5 ~ ~
and a control or regula~ing unit ~con~roller) wuch that the liquefied coolant spray de~ice is connected ~o the source o liquefied coolant while the latter is connected, in ~urn, to the con~roller.
Ad~antageously, the cooling channel can be dispos~d vertically and can be pro~ided, along its opposite 1anks, with copper pipes whose noæzles are trained toward one another and agains~c the bioreceptacle which is introduced between ~he copper pipes so ~ha~ the lique~ied coolant is spr~yed direc~ly on~o ~he surface of the bioreceptacleO
It is especially advanta~eous, in accordance with the invention, to provide a thermal elcment (temperature sensor) within th~ cooling channel such that it lies in direct contac~
with the outer surface of the bioreceptacle and is connecl:ed to the controller for opera~ing same~
Based upon the geometry and materials of the recep~a~le and of the cooling channel, the temperature-time curve for the outer wall of the bioreceptacle, based upon the desired ~empera-ture gradien~ of ~he biolo~ical substance therein, can be readi-i 20 ly calculated and can serve as a se~ point value for ~he con-troller, being compared, at any instant, wi~h the measured temperature to produce a signal which is employed to control ~he supply device for the lique~ied coolant.
This not only has ~he advantage that it can carry out the deep-~reezing under fully sterile conditions, WithOtlt con-tact o the biol.ogical substance with the temperature sensor or any extranecus element, bu~ also avoids the problem of thermal iner~ia or dead ~ime in the control process.
According to another ~eature of the in~en~ion, a holder for the biorecep~acle is pro~ided within the cooling channel between the spray systems and is adapted to receive the 3S2z bioreceptacle sueh ~a~ the lat:ter lies in contac~ w~h ~he suraces o the holder. A surace o the holder ln con~ac~
with the bioreceptacle can be provided wlth a temperature--sensing elemen~ described above while the outer ~urface of ~h~ holder pla~es can be provided with electrical hea~cing devices for the pusposes descrlbed previouslyJ
The holder plates can be sheet me~al elements con~oured to rece~Te the receptacle and can be urged agains~ the la~t0r by spring and/or lever devices which can be used to spread ~:he plates when t~e reccptacle i~ recelved and ~o ~irmly hold the pla~es in surface-to-surface contact with the outer walls of the receptacle when the latter is subjected to deep-freezing.
The hea~ing means can be electrical heating coil5 em-bedded in s~licone rubber ~nd applied to the external surfaces of the pla~es. The amount of heating genera~ed per unit area and the amount of cooling applied by tha spray nozzles per unit area of the plates can be regulated by the controller in accordance with the ~emperat~re measured at the outer ~all o~
the biorecep~acle~
The supply deviee ~or the coolant can, according to s~ill another eature of the invention, include, besides the vessel containing the liquefied coolant7 also a vessel ~or ~he gaseous cs)oling medium such ~hat the liquefied~coolan~
vessel is connected to the gaseous-coolant vessel through the controllerO The interior of ~he l~quefied-coolant re!ceptacle can thus be maintained at a oonstant supera~mosph~ric pressure.
When, before ~he liquefied coolan~ is withdrawin, ~he liquid level ~alls below a prede~ermined height in ~he lique-~fied-coolant re~eptacle~ che oontroller is triggered by ~he pressure drop and feeds gaseous ~edium from the other recepta-cle into tlle liqueied-coolant receptacle to maintain the necessary superatmospheric pressure th~reinO
_ g _ '~S~ 2 ~ apparatus ~or carrying ou~ the process aceord-lng to the immerslon technique comprises a con~ainer for the llque-fied coolant, an immer~icn device and, advantageously, a holder which is suspended from the immersion dev~ce and which includes a pair of plates of low-thermal-conduc~i~lty material between which the bioreceptacle can be dispos~d~ The apparatu~ also includes a con~roller which respo~ds ~o a ~hermal elemen~ in contac~ wi~h the ou~er wall o~ ~he bioreceptacle and a heating device operated by the con~ro~ler. Th~ th~rmal element or ~emp~rature sensor is thus preferably mounted on the inner ~urface of a metal plate be~ween two of which ~he biorecep~acle is receivedO
Brief Des criPtion of ~he Drawin~
~ he above and other objects, features and advan~ages of the presen~ in~Te~tion will become more readily apparent from ~he ~ollowing description, reerence being made ~o the accompa-nying drawing in which:
FIG. 1 is a vertical section through a deep-freezing chamber according ~o the invention, shown in diagrammatic form, and illustrating other por~ions of the apparatus according ~o one embodiment o the inven~ion schematically;
FIG. 2 is a view similar ~o FIG. 1 bu~ illustra~ing ano~her embodiment of the invention;
FI&~ 3 is a block dlagram showing ~ control system for the purpose of ~he presen~ invention;
FIGo 4 is a graph of ~he tempera~ure (ord~nate) versus the cool-down time (abscissa) demons~rating the in~ention; and FIG~ 5 is a series o~ graphs in which the variation in temperature of a frozen suspension at a distan~e within t~e suspensi~n from ~he coolin~ surface (abscissa) is plo~ed as a ~85~Z
~unction of the applied temperature at the surface of the receptacle (ordinate).
Specific Description The embodiment of FIG. 1 uses the spray technique for the deep-freezing of biological substances of the type described while the embodiment of ~IG. 2 utilizes the immersion technique. Both embodiments can make use of a controller of the type shown in FIG. 3.
Throughout this speci~ication, when reference is made to biological substances it is intended to include therein blood, blood components, cell suspensions and cell tissues which may or may not be admixed with protective agents.
In FIG. 1, the sterile hermetically sealed chamber 1 is provided with a deep-freezin~ device 2 including a vertical cooling channel 3 having along its opposite interior walls a spray system 4 for a liquefied coolant, e.g. nitrogen. The spray system can comprise vertical copper pipes having nozzles which train the sprays of liquid nitrogen against the bioreceptacle 6 containing the biological substance, preferably in admixture with the protective agent, and packed and sealed.
Between the spray nozzles, there is provided a holder 5 for the bioreceptacle 6, the holder having external contours conforming to those of the bioreceptacle and preferably being clamped thereagainst by spring or le~er means not shown.
The pla~es of ~hei-holder can be of shee~ metal and are pro-vided along their external sur~aces, i.e. their surfaces turned away from ~he bioreceptacle, with hea~lng coils 7 embedded in layers of silicone rubber. These heating coils permit the heating of the bioreceptacle ~.
On the surace of the holder 5 contacting ~he outer wall of the bioreceptacle 6, there is provided a tempera-ture-sensing element 8 which preferably bear~ against the b~oreceptacle 6 to ensure a finm contact therewlth. ~his tempera~ure sensor maasures the ~emperatur2 on the ~xterior wall of the bioreceptacl2 6 and is connected to a con~roller 9 through which ~he heating coils 7 are energized and which also operates a valve 10 supplying the nozzle systems 4 with the liqueied coolant (liquid nitrogen) from a supply device 11~
Thus ~he amount of liquef~ed coolant supplied per unit time and the heating v~a coils 7 per unit ti~le are regulated by the con~roller 9 in response ~o the thermoelement 8 to pro~
vide a tempera~ure at the outer wall of the receptacle 6 which is a function of ~ime and con~orms to the precalculated temper-atu~e-time curve described aboveO
In order to ensure a constant flow of the liquefied coolant via th~ valve 10 to the nozzles 4, the supply unit 11 is provided with a receptacle 12 ~or the liquefied coolant and means connecting thls recep~acle 12 through the con-troller 9 to a bottle 13 supplying the gaseous coolant a~ an adjustable supera~mospher~c pressure~ Should the pressure fall ln ~he line eeding the noz~les ~ gas is fed rom bottle 13 to the receptacle 120 ~ll058~
FI(~. 2 shows an immersion deep-~reezing system in which a container 20 has a bath o~ the liquefied coolant and is pro-vided at 21 with an immersior device or lowering the biorecep-tacle into this bath.
~ ccording to the inventinn~ this immer~ion device 20 i~
designed to control the depth 1;o which ll:he recep~acle is low~
ered in~o the bath. The immersion de~7ice 21 carries a holder 22 in which the biorecep~acle 28 can be received, the holder 22 being suspended ~rom ~his immersion device. The holder il:self ~0 can be adjus~able so as to c~}mp the bioreceptacle be~ween ~che parts ~:hereof~, 8~g~ via the spring or lever means mentioned previously.
me hvlder 22 rece~ves a pair of me~al plates 25 which rest directly aga~nst the out~r walls of the bioreceptacle ~8 and can be conformed geometrically to them. Along ~he outer suraces of these metal plates, ~here arc provided synthetic-resin plates 23 o~ low thermal conductiv-lt~ which are engaged by the holder 22 only at ~he upper and lower ends. Since the holder 22 can be o~ adjustable siza, it c~n receive plates 23 20 of diff~rent thidcness, the thickness o ~he plates correspond~
ing to t:he desired temperature grad~ert to be maintaine~ in the manner described previously.
For the fine control of the freezing process, as in the system of FIGo 1~ the sur~ace of the metal plates 25 turned away ~rom ~he bioreceptacle 28 can be provided wi~h heating coils 24 embedded in silicone rubber while the surface turned toward and con~ac~ing the bioreceptacle 28 carries a ~empera-- ture- sensing element 26 which i~ connecte~ ~o the controller 27 opcrating the heating element 240 The metal plates 25 serve not only as carriers for the temperature-sensing element 26 and the heating device 24 but also impart a flat predetermined uniform configuration to the synthetic-resin sack containing the biological substances and thus serve to homogenize the heat transfer over the broad surfaces of the bioreceptacle.
As can be seen from FIG. 3, the control or regulator system 9 or 27 can include a memory 30 in which the tempera-ture-time curve is recorded upon calculation as described above, this memory supplying one input to a comparator 31 whose other input is supplies by a temperature sensor 32 which can represent the sensor 8 or 26 of FIGS. 1 and 2. A
different signal from the input of the comparator 31 can be applied to the heater 33, e.g. the electrical heater 7 or 24 of FIGS. 1 and 2, or to the deep-freezing spray control unit 34 which can be the valve 10 of FIG. 1.
By way of example, there is shown in FIG. 4 a graph of temperature-time curve as calculated for blood and the corresponding measured values as obtained by a test probe in the interior of the bioreceptacle. The latter is constituted of polyethylene foil.
The formulas for calculating the temperature-time curve are derived from the partial differential equation for the instantaneous heat conduction:
(I) in which T is the local temperature, x is the position coordinate in the direction of the maximum temperature gradient, t is the time and a is the coefficient of tempera-ture conductivity.
i85~
The boundar~ conditions in the coolant are taken in~o consideration in the oll~wing fc~xmula:
~1 ~x ~[T(xo~ z) ~ To~ (II) x a x in which To is ~he cooling tempera~ure7 3~ is ~he outer wall of the sample~ ~l,is the hea~ conduc~ y of the walï and is the heat ~ransfer coeffici~n~.
~ he other boundary conditions are ob~ained from ~he forrnula III:
1~ ~ An~L~ ~III) ~ - xik ~- x 10 xki = xik representq the location at which the two media meet~
The migration o~ the phase boun~ary in the liquid me~:ium, which corresponds to a migrating heat source7 is considered in ~he following equation:
P~at ~~ ~LI~o (IV) whereby medium i merges into medium ko ~ 15 -~3S8~if~;~
FIG, S shows th~ resul~s ob~ained with a sample having a total th~ckness o 10.8 mm in which, for clarity, the distance :frorn ~he cooled wall has been plot~ed în an expanded scale (see the x value of the absclssa). The values of ~ are thus more sharply drawnO Each cur~e corresponds ~o a given time ~. The bio~og-lcal agent is human blood admixed with 14% by weight of ~ydroxye~hyl starch as a cryogenic protective agen~. In order to keep ~he temperature ~rad~n~ as low as possibleJ as is necessary, 10 for example, ~o pro~e~: the leucocyte, ~he pla~es of low conductivity are 1~ ~mn th~ck plates of low-pressure polye~hyleneO me assembly of recep~acIe holder, biorecep-tacle containing the biological specimen and low-thermal-con-ductivity pla~es is immersed in liquid ni~rogen a~ a ~empera-~ure o ~.1196~o
In cryogeni-~ processes for ~he pre~ervation of b~ologi-cal substances such as blood, blood components, cell ~usp~n-sions and cell tissue~, the majnr problem resides in ~voiding irreversible cell d~mage which can ~esult during the ~reezing process and the subsequent th~wing process, or the minimizir~g of such damage .
It has been proposed heretofore to limit th~ cell damage of biological substances o~ ~he ch~racter described by ~he addition of a cryophylactic protective additive or agent which serves to protect the cells against the effec~s of :Ereezi~g 20 and thawing and which is mixed with the cell su~pension or other biological substance. Such protect~ve agents increase ~he sur~ival rate of ~he frozen cell materials.
Pro~ec~ive add~ res such as glycerin have been used here~ofore, especially ~or the protection o blo~d against t~
effects of the deep-freezing process, and must be washed from the preservPd biological substances after thawing because ~hey can adversely afect the human organismO ~C:onsiderable research ~s~szz has gone in~o ~he developmen'c of biologically innocuous pro-tecti~7e addi~ives and, when such are employed, the survival rate can be :incre~sed.
Investigations have shown tha~ an lmportant factor in avoiding the decompositioa or destruction o:E ~e cells is the tempera~ure gradient with which the cells are ro2en. In other words, there are prede~e~minable cell-speciic ~ime-dependen~ temperature gradients ~t which cellular m~-terial, i~,eO the biolo~ical substances described above, ~an be 10 frozen to ob~ain a survi~al ra~e o about 98%. This latter percentage has been found ~o be a reasonable level for mos~
cryogen~c deep-freezing processes and, when reference i5 made herein ~o ~ime-dependent cell-specific temperatur~ gradients, i~ will be unders~ood that such gradients are intended as will ensure a cell survival rate of about 98% following deep ~reez-ing and thawing.
When ~he speed of the freez~ng process lies ben~ath this ~er~pera~ure gradient, the concen~ra~ion of the extra-cellular liquid is increased during the reezing process by 20 the ~reezing out of water therefrom. This results ln an in-crease in the osmotic pressur~ be~ween the inner-cell and outer-cell media. Furthermore, dur-lng the fre~zing process water is wi~hdrawn from the cells themselves and this results in a concen~ration increase in the intracellular solution as well. miS can gi~e rise to den~turation of ~he proteins in the cell interiorsO While the ef~ects of such processes can be minim~ed by an increase in the sp~ed o~ ~he freezing pro~
cessS t~ere ~e~ertheless is a tendency at both excessively high speeds and low speeds ~o produce intercellular ice which, in any case~ breaks down the cell walls and membranes.
~S~5zz Qf course, the amount and type of protective agent will also influence the desired temperature gradien~ o~ the freezing process. For example, when mix~ures of erythrocytes with glyc erin in high concentrations o about 50% are subjec~ed to deep-~reezing at a temperature gradîent of about ~ K/min (8 de-grees Kel~rin or Cen~igrade per minu~e~, high survival rates of the blsod cells are noted. For unprotected erythrocytes, the optimum temperature gradient is about 50~0 E~/min and even a~
this op~lmum, the maximum survival rate o~ the c211s iS found 10 to be only about ~0~0.
Known processes for the deep-cooliIlg preservation o~
biological substances, which can be contained in so-called b~orecep~acles, eithe~ maintain the biological recep~acle in a liquid nitrogen bath for a predetermined time period, some~imes wi~h shaking in order to ensur~ effective mixture o the bio-logical substance wi~h ~he protective agent, or spray ~he bioreceptacle with liquid nitrogen while monitoring the tem-pera~ure within the interior of the recep~acle.
The recept~cle which can be used in the prior~art ~0 systems and in the invention described ~elow can be any syn-the~ic resin sack or other conta~ner con~entionally used to receive mixtures of blood and protective agents or other bio-logical substances admixed with protec~i~e agentsO
By the technique descr~bed above, the freeging process canno~ be accur~tely maintained at a predetermined cell~spe-cific ~empera ture gradientO
The immersion process, which can be limited only as to t~me, does not permit Yariation in the temperature gradien~
under such controls as ~o main~ain a predetermined cell-specific 30 ~emperature gradient and the optimum temperature gradient ~or any specif cell can, at best, only be approach~d.
~s~
me~sp~ay process permits a monitoring o the change of temperature with time by means of a thermoelemen~ in the interior of ~he bioreceptacle~ but has the diæadvantage khat there ls a large ime lag in the con~rol process, i.e. the reaction time between a change in the supply o the coolant and the re~ulting change in the ~empera~re in ~he ~n~erior of ~he bioreceptacle is considerable. This, ~oo, pre~en~s an accurate control of the ~emperature gradien~O
Qb'ects o~ the Invention Xt is the principal ob~ect o the presen~ invention to provide a process and an apparatus for ~he deep~freezing of biological ~ubs~ances contained in b~oreceptacles, in which during the freezing process a cell-specific temperature gradi-ent op~imum for the specific biological substance can be maintained with high precision and high reproducibili~y.
It is another object of ~he ~nventlon ~o provide a sys~em for the deep-~reezing o biological substances, such as those mentioned abo~e, with or without protect~ve agents, whereby the aforementioned disad~antages are avoided.
Summary o~ ~he Invention These ob~ects are attained, in accordance with the present invention, in a system (proces~ and/or appara~us) whereby the temperature of the outer wall of ~he bioreceptacle ~s controlled as a f~n~tion of time to conform ~o the tempera-ture-t~me curve which ~s calculated to respond to the optiswm ~.emperature gradient for any speclfic biological s~bstance at the outer wall of the bioxeceptacleO
In o~her words, according to the in~ention~ when a predete~mined temperature gradient is to be maintained during the freezing process ~o ensure approximately 98% survival ~s~
rate of ~he cells of this biological substance upon deep~
-freezing, the temperature-time curve a~ the outer wall o ~he biorecep~acle necessary to maintain ~his predetermined temper-a~ure gradient is firs~ calcula~ed and ~he deep-freezing process is con~rolled so that the tempe~ature at the outer wall of the bioreceptacle varias as a 1mction o~ time ~o correspond ~o ~his calcula~ed tempera~ure- ~ime curve .
~ y precalcula~ing the temperature- time cun7e or the ou~cer wall of ~he biorecep~acle, which yields the des~red tem-10 perature gradien~ for ~he biological su~s~ance in the interis:rof the bioreceptacle, and by conforming the change in tempera-ture at ~he outer wall of the bioreceptacle wlth time to correspond to this calculated temperature-time curve, it is possible in accor~nce with the in~ention to carry out the freezing process of any given biological substance with the desired temperature gradien~ without concern or dead ~ime, ~hermal inertia or lag time in a control processO
An important charac~eristic of the inven~ion is tha~
it permits a thermoelement in the interior of the biorecep-2û tacle to be completely dispensed wi~h and i~ alæo eliminatesthe effects of long reaction times resul~ing in dela~s in the change in ~h~ temperature within the bioreceptacle.
Becallse of the mathematical solution which is used ~o calculate the ~emperature within ~he biorec~ptacle, all meas-urements of the temperature wi~hin the interior of ~he bio-logical substance in ~he bioreceptacle can be eliminated~. ~he calculation, of course, takes into consideration the thick-ness of ~he wall of the bioreceptacle, the coefficient of thermal conduction thereo, its heat capacity and the heat-30 -transer coefficien~ between the cooling fluid and the receptacle w~ll and between the receptacle wall and the ~OSB5ZZ
biological substances as well as ~he thermal characteris~ics of ~he liquid layers and the interfacial ~hermal characteristics between the receptacle and the fluidso According to one aspec~ of the inven~ion7 the reeæing procQss is controlled ~o correspond ~o th~ c~lculated ~emp~ra-ture-time curve when the bioreceptacle is sprayed with a lique-fied coolan~ especially ni~rogen, and ~he supply o~ ~he cooling medium per unlt ~ime is regulated in dependence ~pon the ~empe~
ature measured at the out~r ~all of the bioreceptacle. A lag in con~rol~ o~ ~he type which occurs when the measurement Qf ~he temperature takes place in the inter~or of the receptacle, is excluded. The desired ~empera~ure gradien~ can be accurat~ly maintailledn According to ano~her aspec~ or ~eature of the invention, the bioreceptacle can be electrically heated externally during the ~reezing process so that the deslred change in temperature with time is maintained at the ou~ex wall of the bioreceptacle which is sub~ec~ed to deep-freeze cooling by~ for e~ample, the spray-cooling t~chni~ue mentioned above or by immersion cooling, 0~ course, in this case~ ~he heat abstracted by the coolant must exceed the heat del~vered by the electrical heating meansO
I~ h~s been found that the electrical hea~ing technique permits a hlghly exact contro~ of the temperature on the external sur-face of the recep~acle and hence main~aines a predetermined temperature gradient.
It has been ~ound to be highly advan~ageous, in the dee~
freeæing of cells and biological substances which require rela-~ively low temperature gradients of ~ew K/min, ~o avoid cell damage, for e~ample for the ~reezing of corpuscular blood com~
ponents such as thrombocy~es or lymphocytes, to provide ~h~
~195~52;2 freezing apparatus with a pair of pla~ces of low ~hermal conduc-tivity and to dispose the bioreceptacle between these plates.
These plates can be composed of synthe~ic resin and have wall thicknesses which are ~alcula~ed, iLn dependence upon the tem-perature-time curve for the outer wall of t:he recep~acle, to provide the desired temperature as a function of ~cime a~ this outer wall. The assembly of the low-~hermal-conduc~iYity plates and the bioreceptacle can ~hen be immersed in a lique-~ied gas~ e.g. liqu~fied nitrogen~ forming the coolant bathO
The bior~ceptacle can also be hea~ed, preferably elec-trically, along its external sur~ace even in ~he immersion, to maintain the temperature function of ~ime at the ex~rnal sur-face of the receptacle in conformity with ~he calculated tem-perature- time curve .
In this case, the desired temperature grad~ent can be provided as a first appro~ ion by the controll of the wall ~hickness of the plates o low-thermal-conductivity material and can be corr~cted by heating the outer wall of ~he biore-ceptacle in response to an actual measurement of the tempera~
ture a~ this wall, the measured temper~ture being compared with ~he calculated tempera~ure at any ins~ant ln time of the temper-ature-time curve to produce an error signal which controls the heating.
The low-heat-conductivity pla~es ~hus provide a ooa~se control o the freezing speed while the heating operation main-tains the fine control thereof.
An ~pparatus for carrying ou~ the process o~ the pr~sent invention, using the spray-cooling technique, advantageously comprises a cooling channel disposed in a sterile chamber and 30 pxovided wi~h feed means for supplying the liquefi~d coolan~
~ ~ ~ 8 5 ~ ~
and a control or regula~ing unit ~con~roller) wuch that the liquefied coolant spray de~ice is connected ~o the source o liquefied coolant while the latter is connected, in ~urn, to the con~roller.
Ad~antageously, the cooling channel can be dispos~d vertically and can be pro~ided, along its opposite 1anks, with copper pipes whose noæzles are trained toward one another and agains~c the bioreceptacle which is introduced between ~he copper pipes so ~ha~ the lique~ied coolant is spr~yed direc~ly on~o ~he surface of the bioreceptacleO
It is especially advanta~eous, in accordance with the invention, to provide a thermal elcment (temperature sensor) within th~ cooling channel such that it lies in direct contac~
with the outer surface of the bioreceptacle and is connecl:ed to the controller for opera~ing same~
Based upon the geometry and materials of the recep~a~le and of the cooling channel, the temperature-time curve for the outer wall of the bioreceptacle, based upon the desired ~empera-ture gradien~ of ~he biolo~ical substance therein, can be readi-i 20 ly calculated and can serve as a se~ point value for ~he con-troller, being compared, at any instant, wi~h the measured temperature to produce a signal which is employed to control ~he supply device for the lique~ied coolant.
This not only has ~he advantage that it can carry out the deep-~reezing under fully sterile conditions, WithOtlt con-tact o the biol.ogical substance with the temperature sensor or any extranecus element, bu~ also avoids the problem of thermal iner~ia or dead ~ime in the control process.
According to another ~eature of the in~en~ion, a holder for the biorecep~acle is pro~ided within the cooling channel between the spray systems and is adapted to receive the 3S2z bioreceptacle sueh ~a~ the lat:ter lies in contac~ w~h ~he suraces o the holder. A surace o the holder ln con~ac~
with the bioreceptacle can be provided wlth a temperature--sensing elemen~ described above while the outer ~urface of ~h~ holder pla~es can be provided with electrical hea~cing devices for the pusposes descrlbed previouslyJ
The holder plates can be sheet me~al elements con~oured to rece~Te the receptacle and can be urged agains~ the la~t0r by spring and/or lever devices which can be used to spread ~:he plates when t~e reccptacle i~ recelved and ~o ~irmly hold the pla~es in surface-to-surface contact with the outer walls of the receptacle when the latter is subjected to deep-freezing.
The hea~ing means can be electrical heating coil5 em-bedded in s~licone rubber ~nd applied to the external surfaces of the pla~es. The amount of heating genera~ed per unit area and the amount of cooling applied by tha spray nozzles per unit area of the plates can be regulated by the controller in accordance with the ~emperat~re measured at the outer ~all o~
the biorecep~acle~
The supply deviee ~or the coolant can, according to s~ill another eature of the invention, include, besides the vessel containing the liquefied coolant7 also a vessel ~or ~he gaseous cs)oling medium such ~hat the liquefied~coolan~
vessel is connected to the gaseous-coolant vessel through the controllerO The interior of ~he l~quefied-coolant re!ceptacle can thus be maintained at a oonstant supera~mosph~ric pressure.
When, before ~he liquefied coolan~ is withdrawin, ~he liquid level ~alls below a prede~ermined height in ~he lique-~fied-coolant re~eptacle~ che oontroller is triggered by ~he pressure drop and feeds gaseous ~edium from the other recepta-cle into tlle liqueied-coolant receptacle to maintain the necessary superatmospheric pressure th~reinO
_ g _ '~S~ 2 ~ apparatus ~or carrying ou~ the process aceord-lng to the immerslon technique comprises a con~ainer for the llque-fied coolant, an immer~icn device and, advantageously, a holder which is suspended from the immersion dev~ce and which includes a pair of plates of low-thermal-conduc~i~lty material between which the bioreceptacle can be dispos~d~ The apparatu~ also includes a con~roller which respo~ds ~o a ~hermal elemen~ in contac~ wi~h the ou~er wall o~ ~he bioreceptacle and a heating device operated by the con~ro~ler. Th~ th~rmal element or ~emp~rature sensor is thus preferably mounted on the inner ~urface of a metal plate be~ween two of which ~he biorecep~acle is receivedO
Brief Des criPtion of ~he Drawin~
~ he above and other objects, features and advan~ages of the presen~ in~Te~tion will become more readily apparent from ~he ~ollowing description, reerence being made ~o the accompa-nying drawing in which:
FIG. 1 is a vertical section through a deep-freezing chamber according ~o the invention, shown in diagrammatic form, and illustrating other por~ions of the apparatus according ~o one embodiment o the inven~ion schematically;
FIG. 2 is a view similar ~o FIG. 1 bu~ illustra~ing ano~her embodiment of the invention;
FI&~ 3 is a block dlagram showing ~ control system for the purpose of ~he presen~ invention;
FIGo 4 is a graph of ~he tempera~ure (ord~nate) versus the cool-down time (abscissa) demons~rating the in~ention; and FIG~ 5 is a series o~ graphs in which the variation in temperature of a frozen suspension at a distan~e within t~e suspensi~n from ~he coolin~ surface (abscissa) is plo~ed as a ~85~Z
~unction of the applied temperature at the surface of the receptacle (ordinate).
Specific Description The embodiment of FIG. 1 uses the spray technique for the deep-freezing of biological substances of the type described while the embodiment of ~IG. 2 utilizes the immersion technique. Both embodiments can make use of a controller of the type shown in FIG. 3.
Throughout this speci~ication, when reference is made to biological substances it is intended to include therein blood, blood components, cell suspensions and cell tissues which may or may not be admixed with protective agents.
In FIG. 1, the sterile hermetically sealed chamber 1 is provided with a deep-freezin~ device 2 including a vertical cooling channel 3 having along its opposite interior walls a spray system 4 for a liquefied coolant, e.g. nitrogen. The spray system can comprise vertical copper pipes having nozzles which train the sprays of liquid nitrogen against the bioreceptacle 6 containing the biological substance, preferably in admixture with the protective agent, and packed and sealed.
Between the spray nozzles, there is provided a holder 5 for the bioreceptacle 6, the holder having external contours conforming to those of the bioreceptacle and preferably being clamped thereagainst by spring or le~er means not shown.
The pla~es of ~hei-holder can be of shee~ metal and are pro-vided along their external sur~aces, i.e. their surfaces turned away from ~he bioreceptacle, with hea~lng coils 7 embedded in layers of silicone rubber. These heating coils permit the heating of the bioreceptacle ~.
On the surace of the holder 5 contacting ~he outer wall of the bioreceptacle 6, there is provided a tempera-ture-sensing element 8 which preferably bear~ against the b~oreceptacle 6 to ensure a finm contact therewlth. ~his tempera~ure sensor maasures the ~emperatur2 on the ~xterior wall of the bioreceptacl2 6 and is connected to a con~roller 9 through which ~he heating coils 7 are energized and which also operates a valve 10 supplying the nozzle systems 4 with the liqueied coolant (liquid nitrogen) from a supply device 11~
Thus ~he amount of liquef~ed coolant supplied per unit time and the heating v~a coils 7 per unit ti~le are regulated by the con~roller 9 in response ~o the thermoelement 8 to pro~
vide a tempera~ure at the outer wall of the receptacle 6 which is a function of ~ime and con~orms to the precalculated temper-atu~e-time curve described aboveO
In order to ensure a constant flow of the liquefied coolant via th~ valve 10 to the nozzles 4, the supply unit 11 is provided with a receptacle 12 ~or the liquefied coolant and means connecting thls recep~acle 12 through the con-troller 9 to a bottle 13 supplying the gaseous coolant a~ an adjustable supera~mospher~c pressure~ Should the pressure fall ln ~he line eeding the noz~les ~ gas is fed rom bottle 13 to the receptacle 120 ~ll058~
FI(~. 2 shows an immersion deep-~reezing system in which a container 20 has a bath o~ the liquefied coolant and is pro-vided at 21 with an immersior device or lowering the biorecep-tacle into this bath.
~ ccording to the inventinn~ this immer~ion device 20 i~
designed to control the depth 1;o which ll:he recep~acle is low~
ered in~o the bath. The immersion de~7ice 21 carries a holder 22 in which the biorecep~acle 28 can be received, the holder 22 being suspended ~rom ~his immersion device. The holder il:self ~0 can be adjus~able so as to c~}mp the bioreceptacle be~ween ~che parts ~:hereof~, 8~g~ via the spring or lever means mentioned previously.
me hvlder 22 rece~ves a pair of me~al plates 25 which rest directly aga~nst the out~r walls of the bioreceptacle ~8 and can be conformed geometrically to them. Along ~he outer suraces of these metal plates, ~here arc provided synthetic-resin plates 23 o~ low thermal conductiv-lt~ which are engaged by the holder 22 only at ~he upper and lower ends. Since the holder 22 can be o~ adjustable siza, it c~n receive plates 23 20 of diff~rent thidcness, the thickness o ~he plates correspond~
ing to t:he desired temperature grad~ert to be maintaine~ in the manner described previously.
For the fine control of the freezing process, as in the system of FIGo 1~ the sur~ace of the metal plates 25 turned away ~rom ~he bioreceptacle 28 can be provided wi~h heating coils 24 embedded in silicone rubber while the surface turned toward and con~ac~ing the bioreceptacle 28 carries a ~empera-- ture- sensing element 26 which i~ connecte~ ~o the controller 27 opcrating the heating element 240 The metal plates 25 serve not only as carriers for the temperature-sensing element 26 and the heating device 24 but also impart a flat predetermined uniform configuration to the synthetic-resin sack containing the biological substances and thus serve to homogenize the heat transfer over the broad surfaces of the bioreceptacle.
As can be seen from FIG. 3, the control or regulator system 9 or 27 can include a memory 30 in which the tempera-ture-time curve is recorded upon calculation as described above, this memory supplying one input to a comparator 31 whose other input is supplies by a temperature sensor 32 which can represent the sensor 8 or 26 of FIGS. 1 and 2. A
different signal from the input of the comparator 31 can be applied to the heater 33, e.g. the electrical heater 7 or 24 of FIGS. 1 and 2, or to the deep-freezing spray control unit 34 which can be the valve 10 of FIG. 1.
By way of example, there is shown in FIG. 4 a graph of temperature-time curve as calculated for blood and the corresponding measured values as obtained by a test probe in the interior of the bioreceptacle. The latter is constituted of polyethylene foil.
The formulas for calculating the temperature-time curve are derived from the partial differential equation for the instantaneous heat conduction:
(I) in which T is the local temperature, x is the position coordinate in the direction of the maximum temperature gradient, t is the time and a is the coefficient of tempera-ture conductivity.
i85~
The boundar~ conditions in the coolant are taken in~o consideration in the oll~wing fc~xmula:
~1 ~x ~[T(xo~ z) ~ To~ (II) x a x in which To is ~he cooling tempera~ure7 3~ is ~he outer wall of the sample~ ~l,is the hea~ conduc~ y of the walï and is the heat ~ransfer coeffici~n~.
~ he other boundary conditions are ob~ained from ~he forrnula III:
1~ ~ An~L~ ~III) ~ - xik ~- x 10 xki = xik representq the location at which the two media meet~
The migration o~ the phase boun~ary in the liquid me~:ium, which corresponds to a migrating heat source7 is considered in ~he following equation:
P~at ~~ ~LI~o (IV) whereby medium i merges into medium ko ~ 15 -~3S8~if~;~
FIG, S shows th~ resul~s ob~ained with a sample having a total th~ckness o 10.8 mm in which, for clarity, the distance :frorn ~he cooled wall has been plot~ed în an expanded scale (see the x value of the absclssa). The values of ~ are thus more sharply drawnO Each cur~e corresponds ~o a given time ~. The bio~og-lcal agent is human blood admixed with 14% by weight of ~ydroxye~hyl starch as a cryogenic protective agen~. In order to keep ~he temperature ~rad~n~ as low as possibleJ as is necessary, 10 for example, ~o pro~e~: the leucocyte, ~he pla~es of low conductivity are 1~ ~mn th~ck plates of low-pressure polye~hyleneO me assembly of recep~acIe holder, biorecep-tacle containing the biological specimen and low-thermal-con-ductivity pla~es is immersed in liquid ni~rogen a~ a ~empera-~ure o ~.1196~o
Claims (11)
1. A process for the deep freezing of biological sub stances which comprises the steps of:
enclosing the biological substance to be deep frozen in a bioreceptacle, determining the temperature time curve for the outer wall of said bioreceptacle which corresponds to the temperature gradient necessary to freeze all of said biological substance within the receptacle with an effective cell survival rate; and subjecting the bioreceptacle to heat exchange with a fluid coolant at a temperature sufficient to deep freeze said biological substance while controlling the temperature applied to the outer surface of said bioreceptacle as a function of time to conform to said temperature-time curve whereby the biological substance within the receptacle is subjected substantially exact-ly to said temperature gradient.
enclosing the biological substance to be deep frozen in a bioreceptacle, determining the temperature time curve for the outer wall of said bioreceptacle which corresponds to the temperature gradient necessary to freeze all of said biological substance within the receptacle with an effective cell survival rate; and subjecting the bioreceptacle to heat exchange with a fluid coolant at a temperature sufficient to deep freeze said biological substance while controlling the temperature applied to the outer surface of said bioreceptacle as a function of time to conform to said temperature-time curve whereby the biological substance within the receptacle is subjected substantially exact-ly to said temperature gradient.
2. The process defined in claim 1 wherein said biore-ceptacle is sprayed with said liquid coolant and the rate at which said liquid coolant is sprayed is controlled in dependence upon the temperature measured. at the outer wall of said biore-ceptacle.
3. The process defined in claim 1 wherein the biore-ceptacle is immersed in the liquid coolant and the temperature at the outer surface of said bioreceptacle is controlled as a function of time by interposing between said bioreceptacle and said liquid coolant a material of low thermal conductivity and of a thickness determined by said temperature-time curve.
4. The process defined in claim 1, further comprising the step of heating the outer surface of said bioreceptacle to maintain the temperature thereof in conformity with said temperature-time curve during the deep freezing.
5. An apparatus for the deep freezing of biological substances contained in a bioreceptacle, said apparatus comprising:
means for subjecting said bioreceptacle to heat exchange with a liquid coolant at a temperature sufficient to deep freeze the biological substance therein; and means for controlling the temperature at an outer surface of said bioreceptacle as a function of time to conform with a calculated temperature-time curve providing a temperature gradient at which said biological substance is deep frozen with an effective cell survival rate.
means for subjecting said bioreceptacle to heat exchange with a liquid coolant at a temperature sufficient to deep freeze the biological substance therein; and means for controlling the temperature at an outer surface of said bioreceptacle as a function of time to conform with a calculated temperature-time curve providing a temperature gradient at which said biological substance is deep frozen with an effective cell survival rate.
6. The apparatus defined in claim 5 wherein said means for subjecting said bioreceptacle to heat exchange with said liquid coolant comprises a cooling channel, means for supply-ing a liquid coolant to said coolant channel and a control member between said supplying means and said coolant channel, said control means including a controller operatively con-nected to said control member for regulating the supply of the liquid coolant to said cooling channel.
7. The apparatus defined in claim 6 wherein said cooling channel is provided with spray means for spraying said liquid coolant toward said receptacle.
8. The apparatus defined in claim 7, further com-prising a holder in said cooling channel for said biorecep-tacle, said holder having a temperature-sensing element in contact with an outer surface of said bioreceptacle and operatively connected to said controller.
9. The apparatus defined in claim 8 wherein said holder is formed on a sruface opposite said bioreceptacle with heating means controlled by and connected to said controller.
10. The apparatus defined in claim 6 wherein said supplying means includes a container for the liquid coolant and a container for said coolant in gaseous form and at an elevated pressure said controller including means for interconnecting said containers upon a decrease in the pressure within the container for said liquid coolant.
11. The apparatus defined in claim 5 wherein said bioreceptacle is subjected to heat exchange with said liquid coolant by immersing said bioreceptacle in a bath of said liquid receptacle, said means for controlling the temperature at the outer surface of said bioreceptacle including plates of low thermal conductivity interposed between said coolant and a metal plate in contact with said bioreceptacle and of a thick-ness selected to maintain a temperature at said outer surface substantially in conformity with said temperature-time curve, and electrical heating means on said metal plates for fine adjustment of the temperature at said outer surface of said bioreceptacle.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19752557870 DE2557870A1 (en) | 1975-12-22 | 1975-12-22 | METHOD AND DEVICE FOR FREEZING BIOLOGICAL SUBSTANCES |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1058522A true CA1058522A (en) | 1979-07-17 |
Family
ID=5965207
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA268,399A Expired CA1058522A (en) | 1975-12-22 | 1976-12-21 | Method of and apparatus for the deep freezing of biological substances |
Country Status (12)
Country | Link |
---|---|
US (1) | US4107937A (en) |
JP (1) | JPS6048481B2 (en) |
AT (1) | AT351679B (en) |
AU (1) | AU503476B2 (en) |
BE (1) | BE849649A (en) |
CA (1) | CA1058522A (en) |
CH (1) | CH624830A5 (en) |
DE (1) | DE2557870A1 (en) |
DK (1) | DK573976A (en) |
FR (1) | FR2338467A1 (en) |
GB (1) | GB1519710A (en) |
NL (1) | NL7614151A (en) |
Families Citing this family (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4771392A (en) * | 1978-01-30 | 1988-09-13 | Edmund F. Bard | Programmable time varying control system and method |
US4304293A (en) * | 1979-06-18 | 1981-12-08 | Helmholtz-Institut Fur Biomedizinische Technik | Process and apparatus for freezing living cells |
US4327799A (en) * | 1979-06-18 | 1982-05-04 | Helmholtz-Institut Fur Biomedizinische Technik | Process and apparatus for freezing living cells |
FR2460460A1 (en) * | 1979-06-28 | 1981-01-23 | Rivoire Jacques | STABLE AND ACCURATE CRYOGENIC DEVICE |
US4336691A (en) * | 1979-12-13 | 1982-06-29 | The Board Of Trustees Of The Leland Stanford Junior University | Cryojet rapid freezing apparatus |
DE3015672A1 (en) * | 1980-04-23 | 1981-10-29 | Drabert Söhne Minden (Westf.), 4950 Minden | METHOD AND DEVICE FOR IMPROVING THE QUALITY OF RAIL-SHAPED MATERIALS |
US4346754A (en) * | 1980-04-30 | 1982-08-31 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Heating and cooling system |
US4407136A (en) * | 1982-03-29 | 1983-10-04 | Halliburton Company | Downhole tool cooling system |
JPS6056B2 (en) * | 1983-01-14 | 1985-01-05 | 株式会社 ほくさん | Freezing equipment for fertilized eggs, sperm, etc. |
AU584312B2 (en) * | 1984-01-17 | 1989-05-25 | Hoxan Corporation | Method of fabricating frozen fine liver pieces for artificial liver, apparatus for freezing the same, and freezing vessel |
US4531373A (en) * | 1984-10-24 | 1985-07-30 | The Regents Of The University Of California | Directional solidification for the controlled freezing of biomaterials |
GB2168798B (en) * | 1984-12-19 | 1989-05-17 | Charles Raymond Micallef | A method and apparatus for cooling beverage in a bottle |
DE3639760A1 (en) * | 1985-11-28 | 1987-06-04 | Mitsubishi Electric Corp | COOLANT CONTAINER |
USRE33567E (en) * | 1986-02-25 | 1991-04-09 | Micromeritics Instrument Corporation | Temperature controlling apparatus for use with pore volume and surface area analyzers |
DE3610563A1 (en) * | 1986-03-27 | 1987-10-01 | Messer Griesheim Gmbh | DEVICE FOR FREEZING FOODS ON A TROLLEY |
US5510254A (en) * | 1986-04-18 | 1996-04-23 | Advanced Tissue Sciences, Inc. | Three dimensional cell and tissue culture system |
US4963489A (en) * | 1987-04-14 | 1990-10-16 | Marrow-Tech, Inc. | Three-dimensional cell and tissue culture system |
US5863531A (en) * | 1986-04-18 | 1999-01-26 | Advanced Tissue Sciences, Inc. | In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework |
US5032508A (en) * | 1988-09-08 | 1991-07-16 | Marrow-Tech, Inc. | Three-dimensional cell and tissue culture system |
US4721096A (en) * | 1986-04-18 | 1988-01-26 | Marrow-Tech Incorporated | Process for replicating bone marrow in vitro and using the same |
US5266480A (en) * | 1986-04-18 | 1993-11-30 | Advanced Tissue Sciences, Inc. | Three-dimensional skin culture system |
US5160490A (en) * | 1986-04-18 | 1992-11-03 | Marrow-Tech Incorporated | Three-dimensional cell and tissue culture apparatus |
DE3619788A1 (en) * | 1986-06-12 | 1987-12-17 | Messer Griesheim Gmbh | DEVICE FOR COOLING GUMMED LARGE TANKS WITH LIQUID NITROGEN |
JPH0354946Y2 (en) * | 1986-11-25 | 1991-12-05 | ||
US4967382A (en) * | 1987-01-09 | 1990-10-30 | Hall Burness C | Programmable time varying control system and method |
US4790141A (en) * | 1987-12-14 | 1988-12-13 | Industrial Gas And Supply Company | Apparatus and process for quick freezing of blood plasma |
DE8717091U1 (en) * | 1987-12-30 | 1988-03-10 | Colora Messtechnik Gmbh, 7073 Lorch, De | |
JPH07122619B2 (en) * | 1988-10-13 | 1995-12-25 | セイコー電子工業株式会社 | Analysis equipment |
US5248671A (en) * | 1989-02-15 | 1993-09-28 | Board Of Regents, The University Of Texas System | Methods and compositions for treatment of cancer using oligonucleotides |
US5087617A (en) * | 1989-02-15 | 1992-02-11 | Board Of Regents, The University Of Texas System | Methods and compositions for treatment of cancer using oligonucleotides |
US4934151A (en) * | 1989-07-07 | 1990-06-19 | Kyokujitsu Company., Ltd. | Continuous multistage thermal processing apparatus, freezing control method for use by the apparatus, and apparatus for preparing a recording medium for the control method |
US5003787A (en) * | 1990-01-18 | 1991-04-02 | Savant Instruments | Cell preservation system |
US5100676A (en) * | 1990-02-02 | 1992-03-31 | Biosurface Technology, Inc. | Cool storage of cultured epithelial sheets |
ATE161408T1 (en) * | 1990-04-24 | 1998-01-15 | Mark Eisenberg | COMPOSITE EQUIVALENT OF LIVING SKIN |
US5328821A (en) * | 1991-12-12 | 1994-07-12 | Robyn Fisher | Cold and cryo-preservation methods for human tissue slices |
US5533343A (en) * | 1994-07-07 | 1996-07-09 | Tyson Holding Company | Freezing system |
DE4437091C2 (en) * | 1994-10-17 | 2003-07-03 | Andreas Sputtek | freezing containers |
US5689961A (en) * | 1996-01-30 | 1997-11-25 | Organogenesis Inc. | Ice seeding apparatus for cryopreservation systems |
US5827729A (en) * | 1996-04-23 | 1998-10-27 | Advanced Tissue Sciences | Diffusion gradient bioreactor and extracorporeal liver device using a three-dimensional liver tissue |
ATE224536T1 (en) * | 1997-01-13 | 2002-10-15 | Daniel Dr Studer | SAMPLE HOLDER FOR WATER CONTAINING SAMPLES AND METHOD FOR USE THEREOF |
US6293048B1 (en) * | 1999-06-07 | 2001-09-25 | Clay Boulter | Hydroponic feeder and cooler |
DE10015773A1 (en) * | 2000-03-30 | 2001-10-04 | Leica Mikrosysteme Gmbh Wien | Sample holder used in high pressure freezer for preparing aqueous botanical sample, includes sample fastener with recess pressure-sealed, arranged in clearance of housing jacket |
US6684646B2 (en) | 2001-05-22 | 2004-02-03 | Integrated Biosystems, Inc. | Systems and methods for freezing, storing and thawing biopharmaceutical material |
US6698213B2 (en) | 2001-05-22 | 2004-03-02 | Integrated Biosystems, Inc. | Systems and methods for freezing and storing biopharmaceutical material |
US6631616B2 (en) | 2001-05-22 | 2003-10-14 | Richard Wisniewski | Cryopreservation system with controlled dendritic freezing front velocity |
US6635414B2 (en) | 2001-05-22 | 2003-10-21 | Integrated Biosystems, Inc. | Cryopreservation system with controlled dendritic freezing front velocity |
US6945056B2 (en) * | 2001-11-01 | 2005-09-20 | Integrated Biosystems, Inc. | Systems and methods for freezing, mixing and thawing biopharmaceutical material |
EP1665931A3 (en) * | 2001-11-01 | 2006-06-14 | Integrated Biosystems, Inc. | System and methods for freezing and storing biopharmaceutical material |
US7104074B2 (en) | 2001-11-01 | 2006-09-12 | Integrated Biosystems, Inc. | Systems and methods for freezing, storing, transporting and thawing biopharmaceutical material |
CN1315374C (en) * | 2001-11-01 | 2007-05-16 | 综合生物系统公司 | Systems and methods for freezing and storing biopharmaceutical material |
DE10346793B4 (en) * | 2003-10-08 | 2007-04-19 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Cooling device for cryopreservation and corresponding operating method |
IL158599A0 (en) * | 2003-10-26 | 2004-05-12 | Yeda Res & Dev | Methods of modulating hematopoiesis |
WO2005052473A1 (en) * | 2003-11-28 | 2005-06-09 | Snow Factories Sa | Snow making method and apparatus |
US8028532B2 (en) | 2006-03-06 | 2011-10-04 | Sartorius Stedim North America Inc. | Systems and methods for freezing, storing and thawing biopharmaceutical materials |
US20090094995A1 (en) * | 2006-06-15 | 2009-04-16 | Air Liquide Industrial U.S. Lp | System and method for processing food products with fluid recirculation and chilling |
DE102006033098A1 (en) * | 2006-07-14 | 2008-01-24 | Rebholz, Erich, Dr. | Method and device for temporary storage of microbes |
EP2063706A2 (en) * | 2006-09-11 | 2009-06-03 | I.M.T. Interface Multigrad Technology Ltd. | Systems, devices and methods for freezing and thawing biological materials |
WO2009062025A2 (en) * | 2007-11-09 | 2009-05-14 | Praxair Technology, Inc. | Method and system for controlled rate freezing of biological material |
JP2011511623A (en) * | 2008-01-17 | 2011-04-14 | ヴァンス プロダクツ インコーポレイテッド | Quenching equipment for vitrification |
US9557090B2 (en) * | 2011-04-06 | 2017-01-31 | Celltronix | Method and scalable devices for hyper-fast cooling |
EP2710347B1 (en) * | 2011-05-18 | 2020-08-26 | Biocision, LLC | Ventilation assisted passive cell freezing device |
US10098685B2 (en) | 2013-10-30 | 2018-10-16 | Medtronic Cryocath Lp | Feedback system for cryoablation of cardiac tissue |
FR3023714A1 (en) * | 2014-07-18 | 2016-01-22 | Lab Francais Du Fractionnement | INNOVATIVE THERAPY DRUG PACKAGING |
EP4067860A1 (en) * | 2021-03-31 | 2022-10-05 | FEI Company | Method of preparing a cryogenic sample with improved cooling characteristics |
CN113142193B (en) * | 2021-05-27 | 2024-01-30 | 上海理工大学 | Cell program freezing method, system, equipment, medium and device |
CN113803924B (en) * | 2021-09-17 | 2023-08-18 | 山东中科赛奥生物科技有限公司 | Cell refrigerator capable of preventing cell pollution |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2508988A (en) * | 1945-09-17 | 1950-05-23 | Detroit Macoid Corp | Heat control |
GB668450A (en) * | 1949-11-24 | 1952-03-19 | Ateliers Et Chantiers Loire Sa | Method and device for the congelation of liquids |
US2662520A (en) * | 1951-02-06 | 1953-12-15 | Little Inc A | Preservation and storage of biological materials |
DE1186207B (en) * | 1958-06-04 | 1965-01-28 | Krauss Maffei Ag | Heating and cooling device for screw presses processing thermoplastics |
FR1278211A (en) * | 1960-11-08 | 1961-12-08 | Union Carbide Corp | Storage of biological substances, in particular blood |
US3347745A (en) * | 1963-12-06 | 1967-10-17 | Union Carbide Corp | Process for freezing erythrocytes |
US3758382A (en) * | 1968-07-26 | 1973-09-11 | Us Navy | Ve agent process of freezing blood using a hydroxyalkyl starch as cryoprotecti |
US3753357A (en) * | 1970-12-14 | 1973-08-21 | Ovitron Res Corp | Method and apparatus for the preservation of cells and tissues |
GB1418400A (en) * | 1973-03-14 | 1975-12-17 | Nippon Kokan Kk | Method and apparatus for cooling steel |
US3940943A (en) * | 1975-01-22 | 1976-03-02 | The Curators Of The University Of Missouri | Multistage freezing system for preservation of biological materials |
-
1975
- 1975-12-22 DE DE19752557870 patent/DE2557870A1/en not_active Withdrawn
-
1976
- 1976-02-23 AT AT124976A patent/AT351679B/en not_active IP Right Cessation
- 1976-12-20 DK DK573976A patent/DK573976A/en not_active Application Discontinuation
- 1976-12-20 GB GB53220/76A patent/GB1519710A/en not_active Expired
- 1976-12-20 JP JP51152159A patent/JPS6048481B2/en not_active Expired
- 1976-12-20 BE BE6045802A patent/BE849649A/en not_active IP Right Cessation
- 1976-12-20 AU AU20753/76A patent/AU503476B2/en not_active Expired
- 1976-12-20 CH CH1600976A patent/CH624830A5/de not_active IP Right Cessation
- 1976-12-20 NL NL7614151A patent/NL7614151A/en not_active Application Discontinuation
- 1976-12-20 FR FR7638269A patent/FR2338467A1/en active Granted
- 1976-12-21 CA CA268,399A patent/CA1058522A/en not_active Expired
- 1976-12-21 US US05/752,930 patent/US4107937A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DK573976A (en) | 1977-06-23 |
JPS6048481B2 (en) | 1985-10-28 |
AT351679B (en) | 1979-08-10 |
AU503476B2 (en) | 1979-09-06 |
US4107937A (en) | 1978-08-22 |
ATA124976A (en) | 1979-01-15 |
FR2338467A1 (en) | 1977-08-12 |
FR2338467B1 (en) | 1980-06-27 |
CH624830A5 (en) | 1981-08-31 |
GB1519710A (en) | 1978-08-02 |
AU2075376A (en) | 1978-06-29 |
DE2557870A1 (en) | 1977-06-23 |
NL7614151A (en) | 1977-06-24 |
JPS5290619A (en) | 1977-07-30 |
BE849649A (en) | 1977-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1058522A (en) | Method of and apparatus for the deep freezing of biological substances | |
US4327799A (en) | Process and apparatus for freezing living cells | |
CN111565850A (en) | System, apparatus and method for automated thawing of pouch-like storage containers | |
KR101467014B1 (en) | Method and system for controlled rate freezing of biological material | |
CA1130587A (en) | Device for the cryosubstitution of small biological objects for microscopic research especially electron-microscopic investigations | |
Bevilacqua et al. | Ice recrystallization in frozen beef | |
SE453835B (en) | PROCEDURE AND DEVICE FOR HEATING A FLAT CONTAINER FREEZED, SUSPENSION OR DISPOSAL | |
Martino et al. | Ice recrystallization in a model system and in frozen muscle tissue | |
Mader | The thermal behaviour of the water-vein system in polycrystalline ice | |
US6861624B1 (en) | Device for defrosting and/or heating up | |
Bau et al. | Low Rayleigh number thermal convection in a vertical cylinder filled with porous materials and heated from below | |
CN103569511A (en) | Device and method for thawing frozen biological materials | |
Etzel et al. | Enzyme inactivation in a droplet forming a bubble during drying | |
Rubinsky et al. | An analytical method to evaluate cooling rates during cryopreservation protocols for organs | |
Schaefers et al. | Enthalpy measurements of undercooled melts by levitation calorimetry: the pure metals nickel, iron, vanadium and niobium | |
PARSONS et al. | Assessment of the previous heat treatment given to meat products in the temperature range 40–90 C. Part 2: Differential scanning calorimetry, a preliminary study | |
Fisher et al. | Effect of combined heat and radiation on microbial destruction | |
Maesmans et al. | Evaluation of process value distribution with time temperature integrators | |
JP7237406B2 (en) | Cryopreservation method and apparatus | |
Leyendekkers et al. | Thermodynamic properties of water in the subcooled region. I | |
US7805951B2 (en) | Method and apparatus for the crust-freezing/cooling/deep-freezing treatment of products | |
Spinak et al. | Comparisons of the general and Ball formula methods for retort pouch process calculations | |
US20150192357A1 (en) | Control of freezing and thawing of drug substances using heat flow control | |
Campbell et al. | Distribution of heat transfer rate and lethality in a single basket water cascade retort | |
US11014148B2 (en) | Method for measuring and continuously monitoring the heat transfer characteristics of a fluid in a system |